PILL

Direxion Daily Pharmaceutical & Medical Bull 3X Shares
*Unless otherwise stated, data provided by FactSet.

PILL Fund Description

The Direxion Daily Pharmaceutical & Medical Bull 3x Shares ETF provides 3x daily exposure to a multi-factor index of pharmaceutical companies in the US.

PILL Factset Analytics Insight

PILL seeks to deliver daily investment results of 3x the performance of the Dynamic Pharmaceutical Intellidex Index. The underlying index is built using a quant-driven methodology to select and weight pharmaceutical companies based on fundamental and risk factors. Unlike PJP—an unlevered PowerShares’ ETF following the same index—PILL uses derivatives, such as swaps, to achieve its exposure. It’s worth noting that the fund is not a pure pharma play, as some biotech companies also find their way into the index.As with all levered funds PILL should not be expected to deliver 3 times the performance of its index for periods longer than 1 day—compounding and path-dependency can cause significant deviations over longer time frames. PILL is only appropriate for short-term, tactical bets and not as a permanent holding. Hence, the cost of getting in and out of the fund—spreads, commissions, and any premium/discount—is more important than the fund’s expense ratio.PILL originally provided 2 times the daily performance of the index, but failed to attract interest; the fund closed in March 2017. The current version tracks the same index, but with 3x leverage and a higher expense ratio.

PILL MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of July 18, 2018 the Direxion Daily Pharmaceutical & Medical Bull 3X Shares MSCI ESG Fund Quality Score is 3.75 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. PILL ranks in the 0th percentile within its peer group and in the 5th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

PILL CHARTS AND PERFORMANCE

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
PERFORMANCE [as of 07/18/18] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
PILL 14.66% 35.13% 22.44% -- -- -- --
PILL (NAV) 12.89% 35.41% 22.85% -- -- -- --
Dynamic Pharmaceutical Intellidex Index 4.49% 11.88% 10.78% 12.52% -2.59% 12.40% --
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

PILL Summary Data

Direxion
11/15/17
Open-Ended Fund
1.12%
$4.94M
0.75%

PILL Portfolio Data

--
09/25/18

PILL Index Data

Tiered
Multi-Factor
N/A

PILL Fund Structure

No
--
No Policy
N/A
N/A
High
3
Daily

PILL Tax Exposures

20.00% / 39.60%
--
No
Bats Book Viewer
TOP OF BOOK
LAST 10 TRADES
Bats BZX Real-time Quote -
Daily Spread
Premium/Discount
Volume

PILL Factset Analytics Block Liquidity

As of 07/19/18
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of PILL. PILL is rated a N/A out of 5.

PILL Tradability

3,513
$104.05K
2,081
$63.33K
0.75%
$0.22
0.03%
5.32% / -5.75%
None
--
50,000
0.04
0.07%
--
--
$33.10
N/A

PILL MSCI ESG Ratings

3.75 / 10
--
5.02
--
16.76%
32.21